Medidata allies with Apple; Danaher snags Pall for $13.8B;

> Medidata ($MDSO) has connected its eClinical platform to Apple's ($AAPL) ResearchKit. News

> Danaher is buying Pall ($PLL) for $13.8 billion with an eye on the fast-growing world of biopharma services. Story

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.